Stay updated on MAGE-A1 TCR T-cells + Atezolizumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the MAGE-A1 TCR T-cells + Atezolizumab in Solid Tumors Clinical Trial page.

Latest updates to the MAGE-A1 TCR T-cells + Atezolizumab in Solid Tumors Clinical Trial page
- Check5 days agoChange DetectedThe old and new screenshots show the same study record history content with identical entries and structure; no new data or critical updates are present. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check34 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference11%

- Check41 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.3%

- Check55 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2. The 'Back to Top' element was removed, indicating a minor UI cleanup.SummaryDifference0.7%

- Check62 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.7%

- Check70 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location details, while several location-related terms have been removed.SummaryDifference20%

Stay in the know with updates to MAGE-A1 TCR T-cells + Atezolizumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MAGE-A1 TCR T-cells + Atezolizumab in Solid Tumors Clinical Trial page.